An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals.
Offersgaard A, Duarte Hernandez CR, Zhou Y, Duan Z, Gammeltoft KA, Hartmann KT, Fahnøe U, Marichal-Gallardo P, Alzua GP, Underwood AP, Sølund C, Weis N, Bonde JH, Christensen JP, Pedersen GK, Jensen HE, Holmbeck K, Bukh J, Gottwein JM.
Offersgaard A, et al. Among authors: bonde jh.
Sci Rep. 2024 Jul 24;14(1):17039. doi: 10.1038/s41598-024-67570-0.
Sci Rep. 2024.
PMID: 39048693
Free PMC article.